Prevention of late presentation of an HIV infectio

Completed

• Conditions: AIDS; HIV; 10047438

• Registration Number: NL-OMON40685
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 4000

Inclusion Criteria

- >= 18 years of age
- Blood drawing deemed necessary by attending physician for presenting symptoms
- Informed consent

Exclusion Criteria

- < 18 years of age
- No informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is the prevalence of HIV infections</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secondary endpoint is the HIV prevalence in different high-risk groups</p><br>